» Articles » PMID: 6941210

Recovery of Left Ventricular Function Following Discontinuation of Anthracycline Chemotherapy in Children

Overview
Journal Pediatrics
Specialty Pediatrics
Date 1981 Jul 1
PMID 6941210
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Echocardiographic evaluation of left ventricular (LV) performance was performed in 41 children during and following anthracycline chemotherapy. Prior to treatment LV function was normal in all patients; LV shortening fraction was 35.2 +/- 0.7% and percent of predicted velocity of circumferential fiber shortening was 110 +/- 20%. However, the indices measured concurrent with the final anthracycline dose (mean = 308 +/- 16 mg/sq m) demonstrated a significant decline in LV function. The LV shortening fraction had decreased to 29.5 +/- 0.8% and percent of predicted velocity of circumferential fiber shortening decreased to 94 +/- 4% (P less than .01). Four of the eight patients with evidence of significant LV dysfunction had received thoracic or upper abdominal irradiation. Following cessation of anthracycline therapy, LV function improved within one to six months and had returned to normal in all but two patients, both of whom received irradiation. Echocardiography is useful for the identification of anthracycline-induced LV dysfunction. With discontinuation of further anthracycline administration the functional decline in LV performance appears to be reversible.

Citing Articles

Current views on anthracycline cardiotoxicity.

Mele D, Nardozza M, Spallarossa P, Frassoldati A, Tocchetti C, Cadeddu C Heart Fail Rev. 2016; 21(5):621-34.

PMID: 27230651 DOI: 10.1007/s10741-016-9564-5.


Early identification of anthracycline cardiomyopathy: possibilities and implications.

Bulock F, Mott M, Oakhill A, Martin R Arch Dis Child. 1996; 75(5):416-22.

PMID: 8957955 PMC: 1511767. DOI: 10.1136/adc.75.5.416.


Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model.

Dodd D, Atkinson J, Olson R, Buck S, Cusack B, Fleischer S J Clin Invest. 1993; 91(4):1697-705.

PMID: 8386192 PMC: 288149. DOI: 10.1172/JCI116379.


Perioperative complications in patients with anthracycline chemotherapeutic agents.

Burrows F, Hickey P, Colan S Can Anaesth Soc J. 1985; 32(2):149-57.

PMID: 3986652 DOI: 10.1007/BF03010041.


Doxorubicin cardiotoxicity: response of left ventricular ejection fraction to exercise and incidence of regional wall motion abnormalities.

Bae J, Schwaiger M, Mandelkern M, Lin A, Schelbert H Int J Card Imaging. 1988; 3(4):193-201.

PMID: 3074127 DOI: 10.1007/BF01797717.